{"id":"https://openalex.org/W970378722","doi":"https://doi.org/10.1097/01.ijg.0000212274.50229.c6","title":"Travoprost 0.004% With and Without Benzalkonium Chloride: A Comparison of Safety and Efficacy","display_name":"Travoprost 0.004% With and Without Benzalkonium Chloride: A Comparison of Safety and Efficacy","alternate_titles":[],"publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W970378722","doi":"https://doi.org/10.1097/01.ijg.0000212274.50229.c6","mag":"970378722","pmid":"https://pubmed.ncbi.nlm.nih.gov/17224758"},"language":"en","primary_location":{"id":"doi:10.1097/01.ijg.0000212274.50229.c6","doi":"https://doi.org/10.1097/01.ijg.0000212274.50229.c6","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ijg.0000212274.50229.c6","pdf_url":null,"source":{"id":"https://openalex.org/S174695746","display_name":"Journal of Glaucoma","issn_l":"1057-0829","issn":["1057-0829","1536-481X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Glaucoma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W970378722"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048354502","display_name":"Ross A. Lewis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Richard A. Lewis","raw_affiliation_strings":["Grutzmacher and Lewis, Inc, Sacramento, CA, USA","Grutzmacher & Lewis, Inc., Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grutzmacher and Lewis, Inc, Sacramento, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Grutzmacher & Lewis, Inc., Sacramento, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gregory J. Katz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gregory J. Katz","raw_affiliation_strings":["Huron Ophthalmology, Ypsilanti, MI","The Eye Institute, Tulsa, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huron Ophthalmology, Ypsilanti, MI","institution_ids":[]},{"raw_affiliation_string":"The Eye Institute, Tulsa, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark J. Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark J. Weiss","raw_affiliation_strings":["The Eye Institute, Tulsa, OK","Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Eye Institute, Tulsa, OK","institution_ids":[]},{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Theresa A. Landry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theresa A. Landry","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jaime E. Dickerson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jaime E. Dickerson","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John E. James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John E. James","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Steven Y. Hua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven Y. Hua","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. Kenneth Sullivan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Kenneth Sullivan","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dawnelle B. Montgomery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dawnelle B. Montgomery","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David T. Wells","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David T. Wells","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"last","author":{"id":null,"display_name":"and Michael V. W. Bergamini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"and Michael V. W. Bergamini","raw_affiliation_strings":["Alcon Research, Ltd, Fort Worth, TX","Support for this study was provided by Alcon Research, Ltd, Fort Worth, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Research, Ltd, Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]},{"raw_affiliation_string":"Support for this study was provided by Alcon Research, Ltd, Fort Worth, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5048354502"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":13.7891,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.99275119,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"16","issue":"1","first_page":"98","last_page":"103"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/travoprost","display_name":"travoprost","score":0.9909999966621399},{"id":"https://openalex.org/keywords/benzalkonium-chloride","display_name":"benzalkonium chloride","score":0.9950000047683716},{"id":"https://openalex.org/keywords/preservative-free-formulation","display_name":"preservative-free formulation","score":0.8069999814033508},{"id":"https://openalex.org/keywords/open-angle-glaucoma","display_name":"open-angle glaucoma","score":0.9070000052452087},{"id":"https://openalex.org/keywords/ocular-hypertension","display_name":"ocular hypertension","score":1.0},{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.9380000233650208},{"id":"https://openalex.org/keywords/prostamide","display_name":"prostamide","score":0.656000018119812},{"id":"https://openalex.org/keywords/hyperemia","display_name":"hyperemia","score":0.6150000095367432},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.47600001096725464},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C2775919038","wikidata":"https://www.wikidata.org/wiki/Q108126784","display_name":"Benzalkonium chloride","level":2,"score":0.9527146816253662},{"id":"https://openalex.org/C2780276452","wikidata":"https://www.wikidata.org/wiki/Q2193376","display_name":"Travoprost","level":4,"score":0.9180896878242493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4379371404647827},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3691949248313904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3399609327316284},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32898086309432983},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.27121949195861816},{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.05172911286354065},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069557","descriptor_name":"Travoprost","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001548","descriptor_name":"Benzalkonium Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001548","descriptor_name":"Benzalkonium Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001548","descriptor_name":"Benzalkonium Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006068","descriptor_name":"Gonioscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007429","descriptor_name":"Intraocular Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011310","descriptor_name":"Preservatives, Pharmaceutical","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011310","descriptor_name":"Preservatives, Pharmaceutical","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011310","descriptor_name":"Preservatives, Pharmaceutical","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014065","descriptor_name":"Tonometry, Ocular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/01.ijg.0000212274.50229.c6","doi":"https://doi.org/10.1097/01.ijg.0000212274.50229.c6","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ijg.0000212274.50229.c6","pdf_url":null,"source":{"id":"https://openalex.org/S174695746","display_name":"Journal of Glaucoma","issn_l":"1057-0829","issn":["1057-0829","1536-481X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Glaucoma","raw_type":"journal-article"},{"id":"pmid:17224758","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17224758","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of glaucoma","raw_type":"Comparative Study"},{"id":"mag:970378722","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2390276","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1963508707","https://openalex.org/W1966829052","https://openalex.org/W1978986531","https://openalex.org/W1980315610","https://openalex.org/W1981684730","https://openalex.org/W1987558683","https://openalex.org/W1989462542","https://openalex.org/W1989746999","https://openalex.org/W1995230008","https://openalex.org/W2001206574","https://openalex.org/W2005499337","https://openalex.org/W2009358142","https://openalex.org/W2013470532","https://openalex.org/W2064280255","https://openalex.org/W2065572357","https://openalex.org/W2092600288","https://openalex.org/W2141949039","https://openalex.org/W2150121274","https://openalex.org/W2150325002","https://openalex.org/W2162316179","https://openalex.org/W4247541620"],"related_works":["https://openalex.org/W2065228492","https://openalex.org/W1967031111","https://openalex.org/W2047353241","https://openalex.org/W2530797334","https://openalex.org/W2000087895","https://openalex.org/W2011763033","https://openalex.org/W2116581063","https://openalex.org/W2745707104","https://openalex.org/W2022185097","https://openalex.org/W2533389273"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"compare":[2],"the":[3,17,150,174,184],"safety":[4,237],"and":[5,93,106,118,132,170,177,183,207,217,238],"efficacy":[6],"of":[7,16,20,83,152,166,186,209],"travoprost":[8,21,62,68,128,140,213,218,231],"0.004%":[9,22,63,69,129,141,214,219,225,232],"without":[10,70,130,215,226],"benzalkonium":[11],"chloride":[12],"(BAC)":[13],"to":[14,123,135,190,202,230],"that":[15],"marketed":[18],"formulation":[19],"in":[23,172,205,235],"patients":[24,44,187,210],"with":[25,45,51,64,142,212,220,233],"open-angle":[26,46],"glaucoma":[27,47],"or":[28,48,67],"ocular":[29,49],"hypertension.":[30],"METHODS:":[31],"The":[32],"study":[33,99,116,168],"was":[34,146],"a":[35,81],"double-masked,":[36],"randomized,":[37],"parallel":[38],"group,":[39],"multicenter,":[40],"noninferiority":[41],"design.":[42],"Adult":[43],"hypertension":[50],"qualifying":[52],"intraocular":[53],"pressure":[54],"(IOP)":[55],"on":[56,101],"2":[57],"eligibility":[58],"visits":[59,100,117,169],"received":[60],"either":[61],"BAC":[65,71,131,216,227,234],"(n=346),":[66],"(n=344)":[72],"dosed":[73],"once-daily":[74],"each":[75],"evening.":[76],"Patients":[77],"were":[78,96,159,193],"followed":[79],"for":[80,127,139,149,195],"period":[82],"3":[84],"months.":[85],"IOP":[86,111,154],"measurements":[87],"at":[88,98,164],"8":[89],"AM,":[90,92],"10":[91],"4":[94],"PM":[95],"taken":[97],"week":[102,104],"2,":[103],"6,":[105],"month":[107],"3.":[108],"RESULTS:":[109],"Mean":[110],"reductions,":[112],"across":[113],"all":[114],"9":[115,165,167],"times":[119,171],"ranged":[120],"from":[121,133],"7.3":[122],"8.5":[124],"mm":[125,137,162],"Hg":[126,138,163],"7.4":[134],"8.4":[136],"BAC.":[143],"Statistical":[144],"equivalence":[145],"also":[147],"demonstrated":[148],"comparison":[151],"mean":[153],"changes;":[155],"95%":[156],"confidence":[157],"limits":[158],"within":[160],"+/-0.8":[161],"both":[173,196,236],"per":[175],"protocol":[176],"intent-to-treat":[178],"data":[179],"sets.":[180],"Adverse":[181,199],"events":[182,192,200],"number":[185],"discontinued":[188],"owing":[189],"adverse":[191],"similar":[194],"treatment":[197],"groups.":[198],"due":[201],"hyperemia":[203],"occurred":[204],"6.4%":[206],"9.0%":[208],"treated":[211],"BAC,":[221],"respectively.":[222],"CONCLUSION:":[223],"Travoprost":[224],"is":[228],"equivalent":[229],"efficacy.":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W970378722","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
